REHOVOT, Israel & PHILADELPHIA--(Business Wire)-- Rosetta Genomics, Ltd. (Nasdaq: ROSG), a leading developer of microRNA-based molecular diagnostics, today announced the appointment of Kenneth A. Berlin to the position of president and chief executive officer, effective November 2, 2009. Rosetta Genomics` board of directors has recommended that Mr. Berlin also be appointed to serve on the Rosetta Genomics` board of directors. This recommendation will be put to vote at the Company`s upcoming annual shareholders meeting.
